Zenosense, Inc. engages in developing medical devices for the diagnosis of heart attack and cardiac-related illnesses. It includes the detection of the Methicillin-resistant Staphylococcus aureus. The firm uses Acute Myocardial Infarction, and MIDS Cardiac technologies. The company was founded on August 11, 2008 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Zenosense Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Zenosense Inc market cap is $28,700.00.
What is the 52-week high for Zenosense Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zenosense Inc 52 week high is $0.0199 as of September 06, 2025.
What is the 52-week low for Zenosense Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zenosense Inc 52 week low is $0.0003 as of September 06, 2025.
What is Zenosense Inc stock price today?
Zenosense Inc stock price today is $0.0009.
What was Zenosense Inc stock price yesterday?
Zenosense Inc stock price yesterday was $0.0009.
What is the 50-day moving average of Zenosense Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Zenosense Inc 50-day moving average is $0.0009.